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ABSTRACT 
 
The aim of this study is to accurately distinguish 
Parkinson’s disease (PD) participants from healthy controls 
using self-administered tests of gait and postural sway. 
Using consumer-grade smartphones with in-built 
accelerometers, we objectively measure and quantify key 
movement severity symptoms of Parkinson’s disease. 
Specifically, we record tri-axial accelerations, and extract a 
range of different features based on the time and frequency-
domain properties of the acceleration time series. The 
features quantify key characteristics of the acceleration time 
series, and enhance the underlying differences in the gait 
and postural sway accelerations between PD participants 
and controls. Using a random forest classifier, we 
demonstrate an average sensitivity of 98.5% and average 
specificity of 97.5% in discriminating PD participants from 
controls.   
 
Index Terms— Gait, Postural sway, Smartphones, 
Parkinson’s disease, Random forest, Tri-axial acceleration. 
 
1. INTRODUCTION 
 
Parkinson’s disease (PD) is one of the most common 
neurodegenerative disorders, the prevalence of which is 
rapidly growing around the world. It is estimated that from 
2010 to 2030, the number of individuals (65 years or older) 
with Parkinson disease will increase by 77% from 300,000 
to 530,000 [1]. Furthermore, it is reported that for Western 
Europe’s five and the world’s ten, most populous nations, 
the number of people with PD over the age of 50 was 
between 4.1 and 4.3 million in 2005, and will double to 
about 8.7 to 9.3 million by 2020, whereby the burden of PD 
is expected to shift from Western nations to developing, 
Eastern nations [2]. 
 
 
There are no low-cost objective tests for the diagnosis 
of PD. Existing tests for the diagnosis of PD are based on 
subjective neurological examinations, which are performed 
in-clinic. This incurs considerable staff time and costs, and 
logistical costs for patients. There are no inexpensive, and 
yet reliable, tests that can be performed outside the clinic 
with minimal expert supervision, that can accurately track 
symptom progression. It is noteworthy that the current 
clinical consensus understanding of the progression of PD 
after diagnosis comes mostly from longitudinal symptom 
assessments obtained at monthly, and longer, intervals [3]. 
Comparatively little objective information about the 
fluctuation in symptoms on hourly, daily and weekly 
timescales is available. Given the growing number of people 
with Parkinson’s (PWP) and the potential burden it will add 
to national healthcare services, there is tremendous need for 
ubiquitous, objective tests that can be used to support expert 
diagnosis and help improve the quality of life for PWP. 
With advancements in wearable devices [4], several 
researchers have investigated the use of wearable 
accelerometers and other similar technologies to objectively 
measure and monitor key movement severity symptoms in 
PD and related disorders [5]-[9]. It is noteworthy that the 
typical motor characteristics of the PD include tremor, 
bradykinesia, rigidity, and impaired postural balance. 
Existing studies on monitoring PD motor symptoms 
typically use wearable accelerometers or sensors in 
conjunction with video recordings to obtain relevant data in 
a lab-based setting [8]-[9]. On the other hand, given that 
smartphones are relatively inexpensive and ubiquitous, have 
built-in tri-axial accelerometers, and can objectively 
measure the motor symptoms of PD [10]-[11], we 
investigate the efficacy of smartphones to be used as an 
inexpensive, reliable, and an accurate diagnostic support 
tool for PD in a home and community setting. The method 
of this study is to calculate appropriate features from the 
acceleration time series, and thereby enhance the movement 
patterns relevant to PD participants and controls, and use 
these patterns to accurately discriminate PD participants 
from controls. The goal of this study is to reproduce the 
clinical assessment (PD/healthy) as accurately as possible, 
using only the acceleration time series for gait and postural 
sway tests. 
 
2. METHODS 
 
2.1. Data 
 
We conducted a one-month controlled study with 
twenty, age- and gender-matched participants, comprising 
10 PD participants and 10 controls. The Johns Hopkins 
Institutional Review Board reviewed and approved this 
study. Individuals with PD diagnosed clinically by a 
movement disorder specialist and control participants were 
recruited from an academic movement disorder clinic (Johns 
Hopkins). The baseline characteristics of all twenty 
participants are provided in Table 1. 
All participants were provided identical LG Optimus S 
smartphones, capable of recording tri-axial acceleration. For 
the gait test, participants were instructed to walk 20 steps 
forward, turn around, and return back to the starting 
position. For the posture test, participants were instructed to 
stand upright unaided for 30 seconds. All participants were 
instructed to conduct these tests four times daily: just before 
taking their first (morning) dose of levodopa (or in one case, 
rasagiline), one hour later, in mid-afternoon, and before 
going to bed. 
 
Table 1: Baseline characteristics of study participants. 
 
Characteristic PD 
participants 
(N=10) 
Control 
participants 
(N=10) 
Age (SD) 65.1 years (9.8) 57.7 years 
(14.3) 
Percent taking 
levadopa 
90% 0% 
Percent with high 
school education 
100% 100% 
Baseline motor 
Unified Parkinson’s 
Disease Rating 
Score (SD) 
19.6 (6.7) NA 
Baseline Parkinson’s 
Disease 
Questionnaire 39 
score (SD) 
18.5 (16.9) NA 
 
SD: standard deviation; NA: not applicable. 
 
 
2.2. Feature Extraction 
 
We extracted a range of time and frequency-domain 
features from the acceleration time series, partly inspired by 
the list of features extracted in [7]-[9]. We then use a 
classifier to map the features onto a binary diagnostic output 
variable (PD/healthy). Table 2 provides an exhaustive list of 
some of the features extracted in this study, along with a 
brief description of each. 
 
Table 2: Brief description of features extracted from the 
tri-axial accelerometer time series recorded during 
postural sway and gait tests. 
 
Feature Brief Description 
µ Mean  
σ  Standard deviation 
    25
th
 percentile 
    75
th
 percentile 
     Inter-quartile range         
   Median 
    Mode 
   Data range (maximum – minimum) 
   Skewness  
   Kurtosis 
      Mean squared energy 
   Entropy  
     Cross-correlation between the acceleration in 
  and  -axis 
        Mutual information between the acceleration 
in   and  -axis 
        Cross-entropy between the acceleration in   
and  -axis 
1    Extent of randomness in body motion 
     
2     
Instantaneous changes in energy due to body 
motion 
    Autoregression coefficient at time lag 1 
     Zero-crossing rate  
    Dominant frequency component 
   Radial distance 
   Polar angle 
   Azimuth angle 
 
1DFA stands for Detrended Fluctuation Analysis. 
2TKEO stands for Teager-Kaiser Energy Operator. 
 
It is noteworthy that since the data was recorded using 
consumer-grade smartphone accelerometers, we were not 
able to compute some of the primary gait and postural sway 
metrics used in clinical ‘gait lab’ studies, for example, stride 
length, trunk flexion and minimum foot clearance, which 
can potentially be computed using more elaborate wearable 
instrumentation [7]. Encouragingly, despite this limitation, 
we were still able to differentiate PD participants from 
healthy controls with high accuracy, and thus establish the 
feasibility of smartphones for quantifying key motor 
symptoms. As the acceleration time series were recorded at 
irregular time intervals, we applied the Lomb-Scargle 
periodogram to extract frequency-based features [12]. We 
extracted thirty different features from the acceleration time 
series recorded along the x, y and z-axis, and the derived 
absolute acceleration value (aav),      √        . 
In addition to extracting features based on the time and 
frequency-domain properties of the acceleration time series, 
we extracted features based on spherical transformation of 
the tri-axial acceleration time series (radial distance, polar 
angle, and azimuth angle) [13], and demographics (age and 
gender). 
 
2.3. Classification Technique and Classification 
Benchmarks 
 
To provide a clinically meaningful output from the 
acceleration signals, we used a random forest classifier, 
which has shown excellent performance in very similar 
discrimination tasks, such as detecting Parkinson’s disease 
from digital voice signals [14]. Using random forest, we 
map the features extracted from the raw accelerometry 
signals into a determination of whether the participant had 
PD or was healthy. For details on random forests, see [15]. 
To investigate if the accuracy of the random forest 
classifier could have been obtained by chance, we employed 
the following two “naïve benchmarks” that have, by design, 
no discriminative accuracy: 
1) Random classifier – this method is akin to diagnosing a 
subject as having PD based on flipping an unbiased coin. 
Specifically, this classifier assumes PPD:PControl = 0.5:0.5, 
where PPD is the probability of a subject being diagnosed as 
having PD, while PControl is the probability of a subject being 
identified as a control. For example, a subject is classified as 
having PD if the outcome of a fair coin toss is heads; else, 
the subject is identified as a control. 
2) Conditional random classifier – this method is similar to 
the random classifier, with one key difference: the 
probability of an outcome is conditional on the available 
data. This classifier is akin to using a biased coin, such that 
PPD:PControl = NPD:NControl, where NPD and NControl are the 
number of gait and postural sway test instances available for 
PD participants and controls, respectively. This benchmark 
takes into account the difference in size of PD and control 
samples in the acceleration training data set. 
 
2.4. Cross-validation 
 
We used 10-fold cross-validation (CV) with 100 
repetitions [16]. Using this CV method, the data is split into 
a training set (consisting of 90% of the data, used to train 
the classifier) and a testing set (consisting of the remaining 
10% of the data, used for classifier evaluation). The 10-fold 
CV method involves training the methods ten times using 
the training set and evaluating using the test set, ensuring 
that each acceleration signal occurs exactly once in the test 
set. This process was repeated 100 times, and each time the 
data was randomly shuffled prior to training and testing. 
Note that the association between the labels and data was 
kept intact during the process of random shuffling. This 
evaluation method attempts to assess the “generalizability” 
of the classification for other similar, previously unseen 
datasets, and so helps guard against overfitting. 
 
3. RESULTS 
 
To quantify the accuracy of the classifier in 
discriminating PD participants from controls, we employed 
three commonly used performance measures: 
1) Sensitivity (true positive rate) – proportion of PD 
participants correctly identified. 
2) Specificity (true negative rate) – proportion of controls 
correctly identified. 
3) Balanced accuracy – average of sensitivity and 
specificity. 
It is noteworthy that we classify PD participants from 
controls using only the accelerometry data and basic 
demographics such as age and gender. The classification 
performance results are reported in Table 3. 
 
Table 3: Performance measures for the methods used for 
discriminating PD participants from controls. 
 
Method/ 
Measure 
Sensitivity† Specificity* Balanced 
Accuracy‡ 
 
Random  
Forest 
 
 
98.5 ± 1.3 
 
97.6 ± 1.7 
 
98.0 ± 1.1 
 
Random  
Classifier 
 
 
50.0 ± 5.7 
 
50.2 ± 5.7 
 
50.1 ± 3.9 
 
Conditional 
Random 
Classifier 
 
 
67.7 ± 5.1 
 
32.6 ± 5.3 
 
49.9 ± 3.6 
 
 
Note: Results are reported in percentage (%) in the form average ± standard deviation. 
†
Sensitivity = TP/(TP+FN), where TP refers to true positives, while FN stands for 
false negatives. 
*Specificity = TN/(TN+FP), where TN refers to true negatives, while FP stands for 
false positives. 
‡
Balanced Accuracy = (Sensitivity + Specificity)/2. 
 
The two-sided Kolmogorov–Smirnov test was 
employed for group comparison [17]-[18]. Using this test, 
the corresponding distributions of different performance 
measures obtained using random forests and the naïve 
benchmarks were found to be significantly different (p < 
0.001). Based on these results, we can reject the null 
hypothesis that random forests have no discriminative 
accuracy, and statistically verify that the results are 
meaningful and not obtained just by chance. 
 
 
4. SUMMARY AND CONCLUDING REMARKS 
 
Using tri-axial accelerometry data for self-administered 
tests of gait and postural sway recorded via consumer-grade 
smartphones, we were able to distinguish PD participants 
from healthy controls with very high accuracy (Table 3). 
Thus, smartphones appear to be a feasible means for 
performing rapid, self-administered, objective tests of 
critical movement symptoms of PD outside the clinic. 
Most clinical data on PD is low-frequency and recorded 
during periodic assessments in academic research centers. 
Given the feasibility of using smartphones to collect high-
frequency data, future studies could analyze this day-to-day 
data to uncover substantial variations in key symptoms (i.e. 
gait, upper limb, balance, voice, and dexterity impairments) 
with PD. 
In this study, we focused on discriminating PD 
participants from controls solely using accelerometer data. It 
would be worth investigating the efficacy of incorporating 
additional data (for example, reaction times, finger tapping, 
and voice) for the analysis. Future studies could investigate 
monitoring and predicting the severity of PD (as quantified 
using the Unified Parkinson’s Disease Rating Scale 
(UPDRS) or Parkinson’s disease questionnaire (PDQ-39)), 
in order to reproduce the clinicians’ assessment using 
summary measures derived from smartphone data. Future 
probability density estimates of UPDRS or PDQ-39 
generated for different time scales could help clinicians 
make informed decisions regarding drug dosage and timing 
for each individual patient.  
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